Profit jumped to $5.59 billion, or $1.66 per share, in the three months ended September 30, beating expectations of $1.55 per share, according to estimates compiled by LSEG
Sirpiglenastat (DRP-104) induces antitumor efficacy through direct, broad antagonism of glutamine metabolism and stimulation of the innate and adaptive immune systems
Anticancer Drugs 15 , 651662 (2004)
These medications slow gastric emptying to promote satiety and weight loss, but this mechanism can disrupt normal bowel function
What was once viewed primarily as a gut-pancreas hormonal axis for postprandial glucose regulation has now emerged as a central therapeutic pathway influencing inflammation, cardiovascular function, renal and hepatic systems, and even neuroendocrine regulation